NSAIDs-associated risks in patients with rheumatological diseases: analysis of medical prescriptions
https://doi.org/10.31146/1682-8658-ecg-169-9-11-16
Abstract
Introduction. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in curing rheumatologic diseases. To minimize the negative impact of NSAIDs on the gastrointestinal tract (GIT), it is essential to consider the patient’s risk factors and to conduct adequate gastroprotection. The main objective of the study was to assess the knowledge of primary care physicians about NSAIDs — associated gastrointestinal lesions, and to analyze the validity of choosing NSAIDs for patients with rheumatic diseases at the outpatient stage.
Materials and methods. 100 of outpatient physicians were surveyed. 100 patients with rheumatic diseases referred by general practitioners/physicians for a consultation with a rheumatologist were surveyed and their medical records were analyzed.
Results: 28% of rheumatological patients had a low level of risk of complications from the gastrointestinal tract, 53% — moderate level of risk, 19% — high level, but it is not reflected in the medical records. Physicians are not aware enough about the risk factors for NSAID-associated lesions of the gastrointestinal tract. Doctors find it difficult to identify groups of moderate and low risk. In 95% of cases gastroprotective proton pump inhibitorswas conducted regardless of current indications. Rebamipidewas not assigned in any case, although it was mentioned in the survey by 4% of the respondents. Most often, patients with rheumatological pathology are prescribednimesulide (37%), Ketorolac (26%). Coxibe, amtolmetinguacylwere not prescribed by general physicians to a single patient.
Conclusion: Physicians are not aware enough about the risk factors for NSAID-associated lesions of the gastrointestinal tract. NSAIDs are chosen without taking into account modern clinical recommendations.
About the Authors
L. V. Tarasova
FSEBI of HE “The Ulianov Chuvash State University”; BI of HE “Surgut State University”
Russian Federation
Russian Federation
Larisa V. Tarasova, Doctor of Science (Medicine), head of the Department of Faculty and Hospital Therapy; Professor Internal Diseases Department, 428015, Russia, Cheboksary, Moskovsky prospect, 15; 628412, Russia, Khanty-Mansi Autonomous Okrug — Ugra, Surgut, Lenina, 1
I. B. Bashkova
FSEBI of HE “The Ulianov Chuvash State University”; The Federal centre of traumatology, orthopedics and arthroplasty
Russian Federation
Russian Federation
Inna B. Bashkova, PhD (Medicine), associate professor, Department of Faculty and Hospital Therapy; doctor of rheumatology clinic of consultation, 428015, Russia, Cheboksary, Moskovsky prospect, 15; 428020, Russia, Cheboksary, Gladkova str., 33
E. I. Busalaeva
FSEBI of HE “The Ulianov Chuvash State University”; SAI SVE “The Postgraduaute Doctor' Training Institute” of the Ministry Healthcare of the Chuvash Republic
Russian Federation
Russian Federation
Elena I. Busalaeva, PhD (Medicine), Associate Professor, Department of Internal and Family Medicine, The Postgraduaute Doctor' Training Institute, Department of Faculty and Hospital Therapy, 428015, Russia, Cheboksary, Moskovsky prospect, 15; 428018, Russia, Cheboksary, Sespl str., 27
References
1. Karateev A. E., Lila A. M., CHuryukanov M.V., et al. Ocenka effektivnosti algoritma naznacheniya nesteroidnyh protivovospalitel’nyh preparatov (NPVP), osnovannogo na analize faktorov riska lekarstvennyh oslozhnenij, v real’noj klinicheskoj praktike. Rezul’taty vserossijskogo proekta «PRINCIP» (Primenenie Rekomendacij po Ispol’zovaniyu NPVP: Celenapravlennoe Izmenenie Praktiki) [Evaluation of the eff ectiveness of a nonsteroidal antiinflammatory drug (NSAID) selection algorithm based on the analysis of risk factors for drug-induced complications in real clinical practice: The results of the All-Russian PRINCIPLE project (Application of recommendations for NSAID use: a Goal-Oriented Change of Practice)]. Nauchno-prakticheskaya revmatologiya – [Rheumatology Science and Practice], 2017, no. 55(5), рр. 485–492. doi: 10.14412/1995–4484–2017–485–492
2. Karateev A. E., Nasonov E. L., Ivashkin V. T., et al. Racional’noe ispol’zovanie nesteroidnyh protivovospalitel’nyh preparatov. Klinicheskie rekomendacii [Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines]. Nauchno-prakticheskaya revmatologiya – [Rheumatology Science and Practice], 2018, no. 56(Suppl. 1), рр. 1–29. doi: 10.14412/1995–4484–2018–1–29
3. Proekt nacional’nyh klinicheskih rekomendacij (osnovnye polozheniya). Racional’noe ispol’zovanie nesteroidnyh protivovspalitel’nyh preparatov [Draft national clinical guidelines (general provisions). Rational use of nonsteroidal anti-inflammatory drugs]. Nauchnoprakticheskaya revmatologiya – [Rheumatology Science and Practice], 2017, no. 55(4), рр. 452–456. doi: 10.14412/1995–4484–2017–452–456
4. Lazebnik L. B., Golovanova E. V., Alekseenko S. A., et al. Recommendations for the prevention and treatment of esophago-gastro-entero-colopathy induced by nonsteroidal antiinflammatory drugs “NSAID”. Experimental and Clinical Gastroenterology. 2018;151(3): 4–18.
5. Harirforoosh S., Asghar W., Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications // J Pharm Sci (www.cspsCanada.org), 2013; vol. 16, no. 5, pp. 821–827. doi: 10.18433/J3VW2F
6. Karateev A. E. Amtolmetin guacil – novoe sredstvo dlya kupirovaniya ostroj boli [Amtolmetin guatsit – new means for knocking over of an acute pain]. Consilium Medicum. Hirurgiya – [Consilium Medicum. Surgery], 2013, no. 2, pp. 14–20.
7. Pasechnikov V. D. Mekhanizmy zashchity slizistoj obolochki zheludka i NO-vysvobozhdayushchie nesteroidnye protivovospalitel’nye preparaty [Mechanisms of protection of a mucous membrane of a stomach and NO-the releasing nonsteroid anti-inflammatory medicines]. Consilium Medicum, 2013, no. 9, pp. 76–80.
8. Bashkova I. B., Madyanov I. V. Ankiloziruyushchij spondilit: diagnosticheskie aspekty i znachenie nesteroidnyh protivovospalitel’nyh preparatov v ego lechenii (v pomoshch’ vrachu obshchej praktiki) [Ankiloziruyushchy spondilit: diagnostic aspects and value of nonsteroid anti-inflammatory medicines in its treatment (for the aid to the general practitioner)]. RMZH – [RMJ], 2016, no. 2, pp. 101–108.
9. Tarasova L. V., Trukhan D. I., Busalaeva E. I. Adeqvatnaya zashchita zheludka – obiazannost’ vracha luboi specialnosti. K voprosu o primenenii nesteroidnyh protivovospalitel’nyh preparatov v praktike internista. [Adequate protection of the stomach – the duty doctor of any specialty. The question on the use of non-steroidal anti-inflammatory drugs in the practice of internist]. Zdravoohranenie Chuvashii – [Healthcare of Chuvashia], 2018, no 2, pp. 37–46/ doi: 10.25589/GIDUV.2018.12281
10. Karateev A. E. SHest’ nozhej v spinu ingibitoram protonnoj pompy [Six knives in a back to inhibitors of a proton pomp]. Nauchno-prakticheskaya revmatologiya – [Rheumatology Science and Practice], 2013, no. 51(3), рр. 332–40. doi: 10.14412/1995–4484–2013–1509
Review
For citations:
Tarasova L.V., Bashkova I.B., Busalaeva E.I. NSAIDs-associated risks in patients with rheumatological diseases: analysis of medical prescriptions. Experimental and Clinical Gastroenterology. 2019;(9):11-16. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-169-9-11-16
Views:
429
Email this article 